Welcome to the Utah Chapter of the American College of Cardiology
Welcome to the Utah Chapter of the American College of Cardiology
From Left: Sharon Dickinson PA-C, AACC; Teshia Sorensen PharmD, BCPS, AACC and CV Team State Liaison of the Utah Chapter of the American College of Cardiology; Marci Farquhar-Snow, NP, AACC; Nancy Lundy, NP, AACC
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- ACCEL Lite: CAC Use in CV Risk Stratification: CorCal OutcomesIn this episode, Allen J. Taylor, MD, FACC and Joseph Brent Muhlestein, MD, FACC discuss “CorCal: Pooled Cohort Equations versus Coronary Artery Calcium Score in ASCVD Primary Preventionâ€.
- Arrhythmia-Related Trials Featured at ESC Congress 2026: Implications on Clinical PracticeESC Congress 2026 featured several arrhythmia-related clinical trials. SINGLE-AF investigated anticoagulation in patients with atrial fibrillation (AFib) and intermediate stroke risk, PVI-SHAM-AF compared whether catheter ablation improves AFib-related quality of life more than a sham procedure, ASPIRED tested 14-day ECG monitoring in patients with unexplained syncope...
- AMUNDSEN: Does Early Evolocumab Improve Outcomes in Acute MI?Lipid lowering after acute myocardial infarction (MI) is central to secondary prevention, but stepwise therapy may delay LDL-C target attainment. The AMUNDSEN trial, presented at ESC Congress 2026 and simultaneously published in JAMA, assessed whether pre-PCI evolocumab could accelerate LDL-C reduction and improve clinical outcomes.
- ACC CardiaCast: What Clinicians May Be Missing: Overcoming Barriers to Aortic Stenosis DiagnosisThis episode is part of ACC’s ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis. Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis.
- JACC: Advances Report Highlights Continued Sex Disparities in CV Clinical TrialsDespite longstanding inclusion policies to increase the enrollment of women in cardiovascular clinical trials, a brief report published Sept. 25 in JACC: Advances confirms that this disparity persists, with women representing only a third of patients in the late-breaking clinical trials (LBCTs) presented at ACC.26.

Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.